<DOC>
	<DOCNO>NCT00141193</DOCNO>
	<brief_summary>This study prospective , randomize , double-blind , placebo-controlled , multi-center trial compare efficacy safety celecoxib 400mg QD versus placebo reduce occurrence new colorectal adenomas post-polypectomy Month 13 ( Year 1 ) Month 37 ( Year 3 ) study drug administration .</brief_summary>
	<brief_title>Prevention Colorectal Sporadic Adenomatous Polyps ( PRESAP )</brief_title>
	<detailed_description />
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Adenomatous Polyps</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>The subject document colonoscopy cecum perform studyrelated physician adequate preparation result diagnosis clearance adenomatous polyp ( ) within 4 month prior randomization . The subject willing abstain chronic use NSAIDs COX2 inhibitor exclude aspirin cardioprotective dos duration study . The subject history Familial Adenomatous Polyposis Hereditary NonPolyposis Colorectal Cancer . The subject history inflammatory bowel disease .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>